All Infection Prevention & Control articles – Page 34
-
NewsResearchers expand virus-based treatment options for antibiotic-resistant infections
Phages are extremely specific about which strains of a bacterial species they will attack. This has limited their effectiveness against the most antibiotic-resistant strains. To overcome this problem, the research team “trained” the phages by allowing them to evolve together with the bacteria in a controlled laboratory setting for 30 days.
-
NewsDid US cities’ indoor vaccine mandates affect COVID-19 vaccination rates and outcomes?
New research reveals that despite widespread adoption of indoor vaccine mandates in major US cities during the COVID-19 pandemic, there is no consistent evidence that these policies significantly increased vaccination rates or reduced COVID-19–related outcomes. The findings contrast with those from other countries, as national mandates abroad boosted vaccine uptake.
-
NewsApriori Bio and A*STAR Infectious Diseases Labs Announce strategic partnership to advance next generation influenza vaccines
Apriori Bio and the Agency for Science, Technology and Research Infectious Diseases Labs (A*STAR IDL) announced a strategic research partnership to co-develop and evaluate next generation self-amplifying RNA (saRNA) vaccines targeting seasonal and pandemic influenza.
-
NewsThe leading causes of mass mortality events in sea urchins are pathogens, storms, and extreme temperatures
Researchers have identified the primary drivers of sea urchin mass mortality events over recent decades: pathogens, storms, and extreme temperatures. The team have developed an innovative method for genetic sampling in marine environments - using a swab similar to a COVID-19 test, to enable rapid and non-invasive monitoring of marine animals and underwater disease outbreaks.
-
NewsBiomedical Sciences researcher receives nearly $7 million in federal grants to fight STIs
Cynthia Nau Cornelissen, a Distinguished University Professor and associate director of the Institute for Biomedical Sciences at Georgia State University, has received nearly $7 million in two, five-year federal grants to develop vaccines and therapeutics to combat sexually transmitted infections (STIs).
-
NewsExperts urge continued hepatitis B vaccine birth doses for newborns
In a new commentary, leading experts urge that all newborns in the United States continue to receive the first dose of hepatitis B vaccine within 24 hours of birth. Hepatitis B vaccines are safe and effective with over one billion doses administered worldwide.
-
NewsKorea University College of Medicine’s Vaccine Innovation Center selected as lead institution for 2025 Korea-ARPA-H Health Security Project
The Vaccine Innovation Center at Korea University College of Medicine has been selected as the lead institution for a health security research initiative under the Ministry of Health and Welfare’s “2025 Korea-ARPA-H Project.”
-
NewsNew test could allow for more accurate Lyme disease diagnosis
Researchers have developed a new way to detect the Lyme disease bacterium Borrelia burgdorferi, allowing for faster and more accurate diagnosis.
-
NewsNew test could speed detection of three serious regional fungal infections
Researchers have developed a new molecular test capable of detecting three major pathogenic fungi at once — and with a much quicker turnaround than traditional methods.
-
NewsTyphoid conjugate vaccine demonstrates strong safety and immunogenicity: Results from Phase 3 study
PATH and EuBiologics Co., LTD have announced Phase 3 results from a clinical trial of a typhoid conjugate vaccine (TCV), EuTYPH-C Inj.® Multi-dose. EuTYPH-C Inj.® Source: CDC/ Armed Forces Institute of Pathology, Charles N. Farmer This photomicrograph reveals some of the histopathology exhibited in a lymph node tissue ...
-
NewsRainfall and temperature shape mosquito fauna in Atlantic Forest bromeliads, including malaria vectors
Results from a study of mosquito larvae conducted in a natural area in the municipality of São Paulo (Brazil) may help estimate the effects of climate change on disease transmission risk in the biome.
-
CareersSummer studentship: Jonas investigates how metals influence bacterial ecosystems
Jonas Flohr from Portsmouth reports back on his AMI-sponsored summer studentship at Durham University investigating how metals influence bacterial ecosystems.
-
NewsSingle-dose malaria treatment combining four existing drugs as effective as more onerous multi-day, multi-dose regimen
Hundreds of malaria patients participating in a clinical trial in Gabon in West Africa were cured via a single dose of a treatment that utilizes four widely available malaria drugs, according to a new study.
-
NewsDestroying crazy ant nest structure makes them vulnerable to pathogens
Scientists have devised a reliable way to introduce a natural pathogen in colonies, so that invasive tawny crazy ant populations collapse and other native species can recover.
-
NewsStudy reveals that flu vaccine performance varies by age
New research comparing four different flu vaccines found that the ability of the vaccines to activate cells of the immune system that help to protect against infection varied greatly depending on the vaccine type and age of the patient.
-
NewsCracking leishmaniasis: new DNA test to track infection
A new study offers an innovative way to track the spread of leishmaniasis, a parasitic disease affecting both animals and humans. Researchers developed a fast, reliable method to identify sand fly species, detect Leishmania parasites, and determine the source of their blood meals from a single sample.
-
NewsMissing links for rabies in Peru highlights global threats of health inequity
Researchers found that efforts to track dog-related rabies in poorer areas of Peru’s second largest city were lacking even though more dogs were found to have the disease there than in wealthier neighborhoods.
-
NewsEgypt becomes the seventh country in the Eastern Mediterranean Region to eliminate trachoma as a public health problem
The World Health Organization (WHO) today announced that Egypt has successfully eliminated trachoma as a public health problem, marking a historic public health milestone for the country and WHO’s Eastern Mediterranean Region (WHO EMR).
-
NewsHuman PARP gene could be novel target for viral diseases or immune-mediated disorders
Researchershave discovered a human gene, the protein PARP14, plays a role in regulating interferon, part of the body’s innate immune system. Their study could guide development of antiviral therapies for several groups of viral infection.
-
NewsBlood-based immunological signatures for extrapulmonary tuberculosis decoded
Scientists have deciphered the immunological properties of extrapulmonary tuberculosis (EPTB) in the blood of affected patients. The results may help to develop new targeted treatments and tests for this important disease.